Navigation Links
Quest Diagnostics Launches Molecular Cervical Cancer Test Based on National Institutes of Health's TERC Gene Marker
Date:8/30/2012

he widespread availability of the TERC test through Quest Diagnostics achieves this goal because it has the potential to improve the prediction of cervical cancer risk for many women. It highlights the potential for successful public-private collaborations to advance the practice of medicine."

In the United States, women are screened for cervical cancer using Pap and/or human papillomavirus (HPV) tests. Neither Pap nor HPV tests provide definitive results for risk for cervical cancer. Pap tests identify and categorize cellular changes according to risk they will become malignant. HPV tests identify infection with HPV, a virus that causes cervical cancer in some women but is cleared by the immune system in others.

The new Quest Diagnostics test is designed as an adjunct to conventional Pap and HPV tests, and is performed on residual samples from Pap tests. It detects abnormal changes to the TERC gene and chromosome 3 to provide a risk assessment of progression to cervical cancer in women who receive indeterminate Pap and/or HPV test results. TERC results help categorize risk in abnormal Pap tests prior to colposcopy, a procedure to visually inspect cellular changes. Women with the highest risk result may benefit from additional cervical biopsies at colposcopy and more aggressive monitoring and treatment, while women with low-risk TERC and HPV results may be less likely to undergo unnecessary follow-up colposcopy and other procedures.

The new test may be particularly helpful in evaluating women whose Pap test shows mild cellular abnormalities known as low-grade squamous intraepithelial lesions (LSIL). Up to 1.5 million women in the United States receive an LSIL result each year. LSIL diagnosis and treatment is associated with higher patient anxiety, morbidity and cost, although many cases never progress to cancer.

Because cervical cancer may not produce symptoms until advanced stages of disease, scre
'/>"/>

SOURCE Quest Diagnostics Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Endpoints - Clinical Trials in Respiratory Diseases - Pulmonary Function Tests, Biomarkers and Quality of Life Questionnaires All Play Prominent Roles
2. Roper Industries to Acquire Sunquest Information Systems
3. Questcor Reports Second Quarter Financial Results
4. Watson and Actavis Receive FTC Second Request
5. Questcor to Report Second Quarter Results on July 24, 2012
6. Questcor Pharmaceuticals to Present at JMP Securities Healthcare Conference
7. Quest Diagnostics to Release Second Quarter 2012 Financial Results on July 19
8. Quest Diagnostics To Speak At The Wells Fargo Securities 2012 Healthcare Conference
9. Software Pioneer Leaves $10 Million Bequest To Five Leading Non-profits In Health And Drug Policy Reform
10. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
11. Global Prenatal Diagnostics Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  A novel wearable injector slightly larger ... painless for patients to self-inject prescription drugs in the large ... cancer, blood diseases, autoimmune deficiencies, and genetic disorders.  ... to $220B by 2018, according to analysts.   Many of these ...
(Date:1/14/2014)... Jan. 14, 2014 The Brandeis Medical Center, led by Dr. ... a premier and affordable laser tattoo removal experience with the advanced ... is in providing high quality cosmetic services with cutting edge medical ... " Southern California has seen a dramatic increase ...
(Date:1/14/2014)... 2014   NuAire , a manufacturer of ergonomically designed laboratory ... Koki of Japan to sell and ... . NuAire will utilize its network of sales professionals throughout ... to offer assistance in application use, product benefits and ...
Breaking Medicine Technology:Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2NuAire announces sales and service of Hitachi Koki centrifuges in North America 2
... May 11, 2012 Dynatronics Corporation (NASDAQ: DYNT ... nine months ended March 31, 2012 during the morning of ... a conference call for investors later that day at 3:30 ... nine month periods.  Those interested in participating should call (800) ...
... N.C., May 11, 2012  To broaden their marketing ... strategies and tactics to engage key customer groups ... key opinion leaders. But as they shift to ... viral marketing and other approaches, marketing groups are ...
Cached Medicine Technology:New Report Outlines Use of Innovative Marketing to Engage Customer Groups that are Key to the Pharmaceutical Industry 2
(Date:4/17/2014)... California, San Diego School of Medicine report that older ... recent major loss are more likely to be compassionate ... is published in this month,s issue of the ... behaviors are associated with better health and well-being as ... to improve the outcomes of individuals whose deficits in ...
(Date:4/17/2014)... McCullers, MD, was recently invited to submit a ... Reviews Microbiology , one of the world,s foremost ... disease specialist, and chair of the Department of ... Center, analyzed the epidemiology and microbiology of co-infections ... well as more recent 2009 novel H1N1 pandemic. ...
(Date:4/17/2014)... MAYWOOD, Il. (April 17, 2014) Doctors who ... disease called lymphangioleiomyomatosis (LAM) can face an agonizing ... progression of the disease and help relieve shortness ... lung transplants, and sirolimus can cause potentially fatal ... said pulmonologist Dr. Daniel Dilling, medical director of ...
(Date:4/17/2014)... April 17, 2014-- Colic affects about one in five ... numerous pediatric visits during the first several months after ... symptoms was showing promise; however, the April 1, 2014 ... Sung, Valerie) reported on a study, "Probiotics and Infant ... L reuteri for infant colic did not ...
(Date:4/17/2014)... NEW YORK April 17, 2014 EcoHealth Alliance, ... public health issues, published a comprehensive review today examining ... and Marburg virus. The review calls for improved global ... such as the recent outbreak of Ebola in West ... in the countries of Guinea and Liberia. According ...
Breaking Medicine News(10 mins):Health News:The ilk of human kindness 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3
... - QLT Inc. (NASDAQ: QLTI;,TSX: QLT) today announced ... & Co., a leading global investment bank, as ... evaluating and pursuing alternative,strategies to maximize shareholder value., ... assignment because of its,experience in strategic transactions and ...
... Recent developments regarding,North Carolina,s organ and tissue ... Donation to hire Corder Philips to aid in ... These developments include a grant received from the ... to update their online,registry and increase outreach efforts ...
... Deployed Service Members ... ... the,Military Child Education Coalition,s Supporting the Children of the,National Guard and Reserve ... the Minuteman Emergency,Assistance Fund. The contribution will help support the needs of ...
... VANCOUVER and DEERFIELD, IL, Dec. 11 /PRNewswire-FirstCall/ - ... its co-development partner,Astellas Pharma US, Inc. ("Astellas") today ... of the U.S. Food and Drug,Administration (FDA) has ... of vernakalant hydrochloride, an investigational,new drug for rapid ...
... regions activated by beliefs and human feelings, study shows ... disbelief and uncertainty activate distinct areas of the brain, ... online in the Annals of Neurology . ... was monitored using functional magnetci resonance imaging (fMRI) while ...
... genome-wide association studies have identified a genetic variant ... the risk of aggressive prostate cancer. Research teams ... Forest University School of Medicine, the Karolinska Institute ... made the discovery jointly. , Researchers suspect that ...
Cached Medicine News:Health News:QLT Appoints Goldman, Sachs & Co. as financial advisor in review of strategic options to enhance shareholder value 2Health News:North Carolina Coalition on Donation Selects Corder Philips for Newest Campaign 2Health News:TriWest Contributes $25,000 to Washington National Guard Fund and Sponsors Education for Teachers of Military Children 2Health News:FDA Advisory Committee Recommends Approval of KYNAPID(TM) for Acute Atrial Fibrillation 2Health News:FDA Advisory Committee Recommends Approval of KYNAPID(TM) for Acute Atrial Fibrillation 3Health News:FDA Advisory Committee Recommends Approval of KYNAPID(TM) for Acute Atrial Fibrillation 4Health News:FDA Advisory Committee Recommends Approval of KYNAPID(TM) for Acute Atrial Fibrillation 5Health News:FDA Advisory Committee Recommends Approval of KYNAPID(TM) for Acute Atrial Fibrillation 6Health News:Personal Convictions May Control Both Behavior and Emotions 2Health News:Study finds gene linked to aggressive prostate cancer 2Health News:Study finds gene linked to aggressive prostate cancer 3
... long, thick-walled cannula which contains a coaxial ... Helical Loop Basket and a Tip Deflecting ... the outer cannula to carry these two ... right atrium. (Requires a Handle for Tip ...
... non-invasive, virtually pain-free alternative to conventional open ... indications. With Leksell Gamma Knife C the ... improves the ability to mould the radiation ... allows a more selective irradiation and thus ...
Clinac Platinum Plus accelerators offer all the high performance features of the EX series and come with the latest high-precision dose sculpting technology for advanced tumor control....
... The cost-effective, proven and reliable system. ... for rapid patient treatment, fastest beam-on ... - less than 500 milliseconds, pulse-to-pulse ... beam stability, greatest number of multileaf ...
Medicine Products: